THE EFFECT OF ENALAPRIL ON THE FUNCTIONAL AND APOPTOTIC ACTIVITY OF NEUTROPHILS IN PATIENTS WITH RHEUMATIC HEART DISEASE

THE EFFECT OF ENALAPRIL ON THE FUNCTIONAL AND APOPTOTIC ACTIVITY OF NEUTROPHILS IN PATIENTS WITH RHEUMATIC HEART DISEASE

Aim. To study the effect of enalapril on functional activity and vitality of polymorphonuclear cells in rheumatic heart disease complicated by congestive heart failure.Material and methods. 81 patients with rheumatic heart disease and valvular disease were examined. There were 37 males (average age...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Ilyin, A. O. Khrustalev
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	rheumatic heart disease enalapril neutrophils nitric oxide apoptotic activity
Online Access:	https://www.rpcardio.online/jour/article/view/542
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. I. Katelnizkaya, et al.
Published: (2016-01-01)

Untargeted metabolic analysis in serum samples reveals metabolic signature in children with congenital heart failure on enalapril therapy
by: N. J. L. Smeets, et al.
Published: (2025-04-01)

Enalapril and endothelial function in arterial hypertension patients of various age
by: L. I. Katelnitskaya, et al.
Published: (2005-12-01)

Comparative effectiveness of spirapril and enalapril in patients with coronary heart disease-caused chronic heart failure
by: S, Yu. Volkova, et al.
Published: (2006-08-01)

Meta-analysis of nifedipine and enalapril combination therapy for hypertensive patients with coronary heart disease: A systematic review and meta-analysis
by: Kun Wang, et al.
Published: (2025-01-01)

FUNCTIONAL STATE DYNAMICS OF BLOOD CELLS AND ENDOTHELIUM IN PATIENTS WITH ESSENTIAL HYPERTENSION WITH ENALAPRIL TREATMENT
by: O. M. Moisseyeva, et al.
Published: (2003-12-01)

Enalapril in patients after mitral valve replacement
by: O. L. Barbarash, et al.
Published: (2007-08-01)

CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL
by: F. E. Khebodarov, et al.
Published: (2009-10-01)

EXTRACELLULAR DNA AND THE LEVEL OF ITS METHYLATION IN DIFFERENT RHEUMATIC DISEASES
by: N O Shubayeva, et al.
Published: (2012-02-01)

Rheumatic heart disease and enteroviruses
by: L. B. Mitrofanova, et al.
Published: (2005-10-01)

COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL)
by: N. M. Chihladze, et al.
Published: (2016-01-01)

Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
by: S. V. Nedogoda, et al.
Published: (1970-01-01)

Enalapril microhemodynamic effects in patients with essential arterial hypertension
by: L. N. Eliseeva, et al.
Published: (2005-10-01)

Clinical and pharmaco-economic assessment of ACE inhibitors perindopril and enalapril in coronary heart disease patients after coronary artery bypass graft surgery
by: Yu. M. Lopatin, et al.
Published: (2009-06-01)

COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: O. P. Bobrova, et al.
Published: (2015-12-01)

Evaluation of the Hepatotoxicity Induced by Captopril and Enalapril in Rat Liver: A Comparative Study
by: Mohammed Ibrahim, et al.
Published: (2023-12-01)

NITRIC OXIDE ACTIVITY OF NEUTROPHIL IN BLOOD AND CEREBROSPINAL FLUID OF THE CHILDREN WITH BACTERIAL AND VIRAL MENINGITIS
by: V. P. Molochniy, et al.
Published: (2015-08-01)

Enalapril therapy and thrombotic or inflammatory disturbances in essential arterial hypertension
by: O. M. Moiseeva, et al.
Published: (2005-08-01)

Enalapril therapy and thrombotic and inflammatory abnormalities in essential arterial hypertension
by: O. M. Moiseeva, et al.
Published: (2005-12-01)

MANAGEMENT OF PATIENTS WITH RHEUMATIC HEART DISEASES AND CHRONIC HEART FAILURE
by: Aleksey Nikolayevich Kalyagin
Published: (2009-09-01)

The role of NETosis in the pathogenesis of immunoinflammatory rheumatic diseases
by: E. L. Nasonov, et al.
Published: (2023-10-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

A mini review of the pathogenesis of acute rheumatic fever and rheumatic heart disease
by: Shuting Zhuang, et al.
Published: (2025-04-01)

Place of enalapril in treatment of patients with systemic lupus erythematosus and systemic sclerosis
by: L K Kozlova, et al.
Published: (2003-02-01)

COMBINATION THERAPY IN THE MANAGEMENT OF ARTERIAL HYPERTENSION: EFFECTIVENESS OF THE LERCANIDIPINE AND ENALAPRIL COMBINATION
by: L. O. Minushkina
Published: (2013-10-01)

The incidence of acute rheumatic fever and chronic rheumatic heart disease in the Russian population (2011–2012)
by: Rimma Mikhailovna Balabanova
Published: (2014-03-01)

A systematic methodology to capture the global pattern of rheumatic heart disease: the Rheumatic Heart Disease Endemicity Index (RHDEI)
by: Megan Lindstrom, et al.
Published: (2025-07-01)

Oral health experiences of Turkish children with acute rheumatic fever or rheumatic heart disease
by: Aslı Soğukpınar Önsüren, et al.
Published: (2022-02-01)

EFFECT OF VITAMIN C ON APOPTOTIC GERM CELLS OF CRYPTORCHID TESTIS IN RABBITS
by: F.S. AL-Asadi
Published: (2011-06-01)

Engineering strategies for apoptotic bodies
by: Zheyuan Hu, et al.
Published: (2024-09-01)

Rheumatic heart valve disease: navigating the challenges of an overlooked autoimmune disorder
by: Adrien Lupieri, et al.
Published: (2025-03-01)

Acute rheumatic fever and rheumatic heart disease: what's new?
by: D. Yu. Andriyashkina, et al.
Published: (2023-08-01)

Heart rate variability in patients with chronic rheumatic heart disease
by: V. S. Petrov
Published: (2019-11-01)

Planning and Evaluation of Bioequivalence Studies of Enalapril Products
by: D. P. Romodanovsk, et al.
Published: (2018-12-01)

ASSOCIATION BETWEEN RESPIRATORY DYSFUNCTION AND ATMOSPHERE POLLUTION IN CHRONIC RHEUMATIC HEART DISEASE
by: G.S. Taktashov
Published: (2017-03-01)

RESPIRATORY FUNCTION IN PATIENTS WITH RHEUMATIC HEART DISEASE COMPLICATED WITH PULMONARY HYPERTENSION
by: N. A. Shostak, et al.
Published: (2016-01-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Chemical and pharmacological evaluation of the effectiveness of enalapril maleate in exertional angina pectoris in elderly and senile patients
by: I. M. Belay, et al.
Published: (2013-06-01)

COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS
by: O. M. Moiseeva, et al.
Published: (2016-01-01)

Fixed-dose combinations of enalapril and hydrochlorothiazide: effects on arterial hypertension treatment. GARANT Study, Part II
by: S. A. Shalnova, et al.
Published: (1970-01-01)